Controlling Transcription: Delivery May Be Biggest Obstacle

Protein structure information from X-ray crystallography and bioinformatics has given biochemists a potentially potent anticancer target: specific segments of DNA's double helix. But, as a group of biochemists at a fall conference sponsored by the National Foundation for Cancer Research agreed, knowing the structure of proteins and protein complexes that bind to DNA segments and turn genes off and on may be only half the battle. Proteins or large synthetic molecules should, in theory, be able t

Paul Smaglik
Jan 17, 1999

Protein structure information from X-ray crystallography and bioinformatics has given biochemists a potentially potent anticancer target: specific segments of DNA's double helix. But, as a group of biochemists at a fall conference sponsored by the National Foundation for Cancer Research agreed, knowing the structure of proteins and protein complexes that bind to DNA segments and turn genes off and on may be only half the battle. Proteins or large synthetic molecules should, in theory, be able to repair defective genes whose malfunctions give rise to tumors. But large molecules degrade in the body. And delivery could prove difficult.


Alanna Schepartz
Better understanding how transcription factors work may be the logical first step, notes Alanna Schepartz, a Yale University chemist. That, of course, is easier said than done, because multiple proteins and protein complexes interact with any given DNA segment. Schepartz and colleagues conducted experiments to learn how the human...

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?